Zoetis shareholders approve officer exculpation; director Linda Rhodes retires

Zoetis Inc.

Director Linda Rhodes retired from the board effective May 21, 2024, per the retirement policy.
Shareholders approved officer exculpation amendment (345.3M for, 40.7M against), limiting officer liability.
All 12 director nominees elected; say-on-pay passed with 351.1M votes for.
Shareholder proposal on director resignation policy defeated (53.8M for, 331.8M against).
KPMG ratified as independent auditor for 2024 with 401.4M votes for.

item 5.02 item 5.03 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Linda Rhodes

Director

ZTS · Zoetis Inc.

Effective: 2024-05-21
Filed: May 23, 2024, 7:59 PM ET

Effective May 21, 2024, Dr. Linda Rhodes retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2024 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Linda Rhodes retired as Director at Zoetis Inc..

Action: retired
Role: Director

Exact text from the filing

Effective May 21, 2024, Dr. Linda Rhodes retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2024 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.

View on SEC.gov

Zoetis Inc. filing history →

Source: SEC EDGAR

accession 0001555280-24-000257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.